| Home > Publications Database > Prediction of dementia of Alzheimer type by different types of subjective cognitive decline. > print |
| 001 | 154273 | ||
| 005 | 20240227110955.0 | ||
| 024 | 7 | _ | |a 10.1002/alz.12163 |2 doi |
| 024 | 7 | _ | |a pmid:33140565 |2 pmid |
| 024 | 7 | _ | |a 1552-5260 |2 ISSN |
| 024 | 7 | _ | |a 1552-5279 |2 ISSN |
| 024 | 7 | _ | |a altmetric:93702205 |2 altmetric |
| 037 | _ | _ | |a DZNE-2021-00127 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Jessen, Frank |0 P:(DE-2719)2000032 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a Prediction of dementia of Alzheimer type by different types of subjective cognitive decline. |
| 260 | _ | _ | |a Hoboken, NJ |c 2020 |b Wiley |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1709028555_12962 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a ISSN 1552-5279 not unique: **3 hits**. |
| 520 | _ | _ | |a Subjective cognitive decline (SCD) is a risk condition for dementia, including dementia of Alzheimer type (DAT).We report sensitivity, specificity, positive and negative predictive values (PPV, NPV) for conversion to all-cause dementia, and DAT in different SCD types (decline in memory, assocated worries, longitudinal consitency, of the AgeCoDe study (n = 2.402, 12 years follow-up).82.7% of those converting to any dementia and 84.4% of those converting with DAT at follow-up, reported memory decline and fulfilled criteria of SCD at least at one time point before. SCD with worries at two consecutive time points showed a specificity of 92.2% for any dementia and also for DAT as well as a PPV of 44.3% for any dementia and of 36.9% for DAT at follow-up at the expense of low sensitivity.Different SCD subtypes were either sensitive or specific for future all-cause dementia and DAT in cognitively unimpaired individuals. Modest PPV of the most specific SCD subtypes were achieved in this low prevalence population. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Alzheimer's disease |2 Other |
| 650 | _ | 7 | |a negative predictive value |2 Other |
| 650 | _ | 7 | |a positive predictive value |2 Other |
| 650 | _ | 7 | |a subjective cognitive decline |2 Other |
| 650 | _ | 2 | |a Alzheimer Disease: classification |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Anxiety: psychology |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Germany: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Longitudinal Studies |2 MeSH |
| 650 | _ | 2 | |a Neuropsychological Tests: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Predictive Value of Tests |2 MeSH |
| 650 | _ | 2 | |a Prevalence |2 MeSH |
| 650 | _ | 2 | |a Self Report |2 MeSH |
| 700 | 1 | _ | |a Kleineidam, Luca |0 P:(DE-2719)2812139 |b 1 |u dzne |
| 700 | 1 | _ | |a Wolfsgruber, Steffen |0 P:(DE-2719)2810544 |b 2 |u dzne |
| 700 | 1 | _ | |a Bickel, Horst |b 3 |
| 700 | 1 | _ | |a Brettschneider, Christian |b 4 |
| 700 | 1 | _ | |a Fuchs, Angela |b 5 |
| 700 | 1 | _ | |a Kaduszkiewicz, Hanna |b 6 |
| 700 | 1 | _ | |a König, Hans-Helmut |b 7 |
| 700 | 1 | _ | |a Mallon, Tina |b 8 |
| 700 | 1 | _ | |a Mamone, Silke |b 9 |
| 700 | 1 | _ | |a Pabst, Alexander |b 10 |
| 700 | 1 | _ | |a Pentzek, Michael |b 11 |
| 700 | 1 | _ | |a Roehr, Susanne |b 12 |
| 700 | 1 | _ | |a Weeg, Dagmar |b 13 |
| 700 | 1 | _ | |a Jochen, Werle |b 14 |
| 700 | 1 | _ | |a Weyerer, Siegfried |b 15 |
| 700 | 1 | _ | |a Wiese, Birgitt |b 16 |
| 700 | 1 | _ | |a Maier, Wolfgang |0 P:(DE-HGF)0 |b 17 |
| 700 | 1 | _ | |a Scherer, Martin |b 18 |
| 700 | 1 | _ | |a Riedel-Heller, Steffi |b 19 |
| 700 | 1 | _ | |a Wagner, Michael |0 P:(DE-2719)2000057 |b 20 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1002/alz.12163 |g Vol. 16, no. 12, p. 1745 - 1749 |0 PERI:(DE-600)2201940-6 |n 12 |p 1745 - 1749 |t Alzheimer's and dementia |v 16 |y 2020 |x 1552-5279 |
| 856 | 4 | _ | |u https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12163 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/154273/files/DZNE-2021-00127_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/154273/files/DZNE-2021-00127_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:154273 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2000032 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2812139 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2810544 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 20 |6 P:(DE-2719)2000057 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 913 | 2 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2021-01-28 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-28 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-28 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ALZHEIMERS DEMENT : 2021 |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-11 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ALZHEIMERS DEMENT : 2021 |d 2022-11-11 |
| 920 | 1 | _ | |0 I:(DE-2719)1011102 |k AG Jessen |l Clinical Alzheimer’s Disease Research |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1011201 |k AG Wagner |l Neuropsychology |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)7000001 |k U Clinical Researchers - Bonn |l U Clinical Researchers - Bonn |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1011102 |
| 980 | _ | _ | |a I:(DE-2719)1011201 |
| 980 | _ | _ | |a I:(DE-2719)7000001 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|